Sato Pharmaceutical Co., Ltd. – 11/21/2025. Country: Japan. Record Type: 483
Similar Posts
About CDER Small Business and Industry Assistance (SBIA)
CDER Small Business and Industry Assistance (SBIA) helps small pharmaceutical business and industry navigate the wealth of information that FDA offers, and provides assistance in understanding the regulation of human drug products.Lockout Supplements Issues Voluntary Nationwide Recall of Boner Bears Chocolate Syrup Due to Undeclared Sildenafil
02/252026-McKinney, Texas, Lockout Supplements is voluntarily recalling all lots of Boner Bears Chocolate Syrup. This product has been found to contain sildenafil not listed on the product label.Maiva Pharma Private Limited – 2/20/2026
Maiva Pharma Private Limited – 2/20/2026. Country: India. Record Type: 483Investigational New Drug (IND) Application
Get to know the investigational new drug application (IND). This includes the types, laws and regulations, and emergency use of INDs.WILDMAN may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use WILDMAN, a product promoted and sold for sexual enhancement on various websites, including www.loveproducts.net, and possibly in some retail stores.Delta Pharma Inc. Ripley, MS. 483 issued 11/21/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 11/21/2025
Short Title (70 char) Delta Pharma Inc. Ripley, MS. 483 issued 11/21/2025
FEI Number 3004034796
Firm Name Delta Pharma Inc
Record Type 483
State MS
Establishment Type Outsourcing Facility